Kinase inhibitors have become a clinically important family of prescription drugs that are part of targeted therapies, and kinase inhibitors are widely used in the immunology area to treat arthritis. The most direct and easiest approach to the design of kinase inhibitors is to target the ATP pocket, which is located inside the deep cleft between the two structural domains of the kinase. The hinge is a single string of the amino acid segments that connects the two structural domains. Among the 23 kinase inhibitors that have entered the market to date, most of them are kinase ATP-binding pocket inhibitors, and this type of inhibitor can be considered as an ATP mimetics because they interact similarly to that of ATP.
BOC Sciences has focused on studying and designing the hinge-binding agents required for kinase ATP-pocket inhibitors. Our hinge binders can form one to three hydrogen bonds with the hinge, and be able to recognize potential inhibitors that target the ATP pocket.
Based on detailed structural analysis of the known and most potent kinase inhibitors, BOC Sciences has developed a series of unique structural filters that are designed to identify potential inhibitors targeting the ATP pocket.
Figure 1. Discovery of a novel kinase hinge binder fragment by dynamic undocking. (Rachman, M.; et al. 2020)
BOC Sciences provides professional, rapid and high-quality services of Kinase Hinge Binders Library design at competitive prices for global customers. Personalized and customized services of Kinase Hinge Binders Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.